DK1042363T3 - Nye anti-HIV-immunogener (toxoider), fremgangsmåde til fremstilling heraf og anvendelse heraf til at forebygge og behandle AIDS - Google Patents
Nye anti-HIV-immunogener (toxoider), fremgangsmåde til fremstilling heraf og anvendelse heraf til at forebygge og behandle AIDSInfo
- Publication number
- DK1042363T3 DK1042363T3 DK98959984T DK98959984T DK1042363T3 DK 1042363 T3 DK1042363 T3 DK 1042363T3 DK 98959984 T DK98959984 T DK 98959984T DK 98959984 T DK98959984 T DK 98959984T DK 1042363 T3 DK1042363 T3 DK 1042363T3
- Authority
- DK
- Denmark
- Prior art keywords
- toxoids
- preventing
- preparation
- methods
- new anti
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 230000036436 anti-hiv Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9716589A FR2773156B1 (fr) | 1997-12-26 | 1997-12-26 | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1042363T3 true DK1042363T3 (da) | 2006-10-30 |
Family
ID=9515202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98959984T DK1042363T3 (da) | 1997-12-26 | 1998-12-14 | Nye anti-HIV-immunogener (toxoider), fremgangsmåde til fremstilling heraf og anvendelse heraf til at forebygge og behandle AIDS |
Country Status (16)
Country | Link |
---|---|
US (2) | US6420141B1 (de) |
EP (3) | EP1042363B1 (de) |
JP (2) | JP2001527029A (de) |
AR (1) | AR014946A1 (de) |
AT (2) | ATE330970T1 (de) |
AU (2) | AU1568499A (de) |
BR (1) | BR9814473A (de) |
CA (1) | CA2316811A1 (de) |
CY (1) | CY1106152T1 (de) |
DE (2) | DE69835031T2 (de) |
DK (1) | DK1042363T3 (de) |
ES (1) | ES2267199T3 (de) |
FR (1) | FR2773156B1 (de) |
MX (1) | MXPA00006263A (de) |
PT (1) | PT1042363E (de) |
WO (2) | WO1999033872A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2773156B1 (fr) | 1997-12-26 | 2000-03-31 | Biovacs Inc | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
FR2781158B1 (fr) | 1998-07-15 | 2002-12-13 | Vacs Internat | Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications |
CA2358385C (en) | 1998-12-31 | 2013-08-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
FR2792639B1 (fr) | 1999-04-26 | 2003-06-06 | Neovacs | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
US20050226890A1 (en) * | 1999-08-12 | 2005-10-13 | Cohen David I | Tat-based vaccine compositions and methods of making and using same |
CN1326873C (zh) * | 2000-01-31 | 2007-07-18 | 史密丝克莱恩比彻姆生物有限公司 | 用于hiv预防或治疗性免疫的疫苗 |
WO2005090392A1 (en) * | 2004-03-16 | 2005-09-29 | Inist Inc. | Tat-based tolerogen compositions and methods of making and using same |
NO314587B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV |
EP2412242A3 (de) | 2001-07-05 | 2012-06-13 | Novartis Vaccines and Diagnostics, Inc. | Polypeptide vom HIV-Typ C codierende Polynucleotide, Polypeptide und deren Verwendung |
FR2828404B1 (fr) * | 2001-08-10 | 2005-07-15 | Neovacs | Superimmunogene composite a usage vaccinal bifonctionnel pour le traitement des maladies associees a un desordre tissulaire stromal |
WO2003054006A2 (en) * | 2001-12-11 | 2003-07-03 | Aventis Pasteur | Mutated hiv tat |
WO2003097675A1 (en) * | 2002-05-16 | 2003-11-27 | Bavarian Nordic A/S | Fusion protein of hiv regulatory/accessory proteins |
US20040115830A1 (en) * | 2002-09-25 | 2004-06-17 | Igor Touzov | Components for nano-scale Reactor |
FR2862306B1 (fr) | 2003-11-17 | 2008-05-30 | Aventis Pasteur | Composition vaccinale |
US7927580B2 (en) * | 2004-03-16 | 2011-04-19 | Nanirx, Inc. | Tat-based immunomodulatory compositions and methods of their discovery and use |
AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
US8168165B2 (en) * | 2008-12-23 | 2012-05-01 | Abbott Laboratories | Alkylated interleukin-18 compositions |
CN102405057B (zh) | 2009-03-23 | 2016-05-25 | 那尼尔科斯治疗公司 | 用免疫刺激性Hiv Tat衍生物多肽治疗癌症 |
EP3187585A1 (de) | 2010-03-25 | 2017-07-05 | Oregon Health&Science University | Cmv-glycoproteine und rekombinante vektoren |
PL2691530T3 (pl) | 2011-06-10 | 2019-02-28 | Oregon Health & Science University | Glikoproteiny i rekombinowane wektory CMV |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
WO2015051245A1 (en) | 2013-10-04 | 2015-04-09 | Pin Pharma, Inc. | Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
KR20170042605A (ko) * | 2014-08-18 | 2017-04-19 | 사노피 파스퇴르 인코포레이티드 | 알킬화된 인플루엔자 백신 |
EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
FR3057438B1 (fr) | 2016-10-14 | 2020-10-02 | Univ Limoges | Procede d'elicitation d'une plante au moyen d'extraits de champignons macroscopiques comestibles |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4258029A (en) | 1979-04-23 | 1981-03-24 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
DE3650175T3 (de) * | 1985-04-29 | 2007-09-06 | Bio-Rad Laboratories, Inc., Hercules | Synthetische antigene zum nachweis von aids. |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
WO1991018454A1 (en) * | 1990-05-18 | 1991-11-28 | Centre National De La Recherche Scientifique | Compositions capable of blocking cytotoxicity of viral regulatory proteins and neurotoxic symptoms associated with retroviral infection |
WO1994015634A1 (en) * | 1992-12-30 | 1994-07-21 | Matthias Rath | Tat and rev oligopeptides in hiv treatment |
WO1995031999A1 (en) | 1994-05-23 | 1995-11-30 | Immunogiology Research Institute, Inc. | Compositions of transactivating proteins of human immunodeficiency virus |
WO1996027389A1 (fr) * | 1995-03-08 | 1996-09-12 | Neovacs | Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant |
US6200575B1 (en) * | 1996-03-07 | 2001-03-13 | Neovacs | Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them |
FR2773156B1 (fr) | 1997-12-26 | 2000-03-31 | Biovacs Inc | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
-
1997
- 1997-12-26 FR FR9716589A patent/FR2773156B1/fr not_active Expired - Fee Related
-
1998
- 1998-12-14 US US09/582,519 patent/US6420141B1/en not_active Expired - Lifetime
- 1998-12-14 EP EP98959984A patent/EP1042363B1/de not_active Expired - Lifetime
- 1998-12-14 ES ES98959984T patent/ES2267199T3/es not_active Expired - Lifetime
- 1998-12-14 AU AU15684/99A patent/AU1568499A/en not_active Abandoned
- 1998-12-14 AT AT98959984T patent/ATE330970T1/de active
- 1998-12-14 DE DE69835031T patent/DE69835031T2/de not_active Expired - Lifetime
- 1998-12-14 DK DK98959984T patent/DK1042363T3/da active
- 1998-12-14 PT PT98959984T patent/PT1042363E/pt unknown
- 1998-12-14 WO PCT/FR1998/002727 patent/WO1999033872A1/fr active IP Right Grant
- 1998-12-22 AT AT98964219T patent/ATE412006T1/de not_active IP Right Cessation
- 1998-12-22 EP EP98964219A patent/EP1041888B1/de not_active Expired - Lifetime
- 1998-12-22 MX MXPA00006263A patent/MXPA00006263A/es not_active IP Right Cessation
- 1998-12-22 BR BR9814473-1A patent/BR9814473A/pt not_active Application Discontinuation
- 1998-12-22 DE DE69840152T patent/DE69840152D1/de not_active Expired - Fee Related
- 1998-12-22 JP JP2000526120A patent/JP2001527029A/ja active Pending
- 1998-12-22 AU AU19397/99A patent/AU1939799A/en not_active Abandoned
- 1998-12-22 CA CA002316811A patent/CA2316811A1/en not_active Abandoned
- 1998-12-22 EP EP07123075A patent/EP1975173A1/de not_active Withdrawn
- 1998-12-22 WO PCT/US1998/027263 patent/WO1999033346A1/en active Application Filing
- 1998-12-23 AR ARP980106645A patent/AR014946A1/es active IP Right Grant
-
2000
- 2000-05-17 US US09/572,451 patent/US7022326B1/en not_active Expired - Fee Related
-
2006
- 2006-06-09 JP JP2006161682A patent/JP2006257102A/ja active Pending
- 2006-08-31 CY CY20061101235T patent/CY1106152T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1042363B1 (de) | 2006-06-21 |
AU1568499A (en) | 1999-07-19 |
US7022326B1 (en) | 2006-04-04 |
BR9814473A (pt) | 2001-10-23 |
EP1042363A1 (de) | 2000-10-11 |
AU1939799A (en) | 1999-07-19 |
CY1106152T1 (el) | 2011-06-08 |
MXPA00006263A (es) | 2003-07-14 |
PT1042363E (pt) | 2006-11-30 |
EP1041888A4 (de) | 2000-10-18 |
WO1999033346A1 (en) | 1999-07-08 |
EP1041888A1 (de) | 2000-10-11 |
ATE412006T1 (de) | 2008-11-15 |
CA2316811A1 (en) | 1999-07-08 |
FR2773156B1 (fr) | 2000-03-31 |
JP2001527029A (ja) | 2001-12-25 |
FR2773156A1 (fr) | 1999-07-02 |
DE69840152D1 (de) | 2008-12-04 |
WO1999033872A1 (fr) | 1999-07-08 |
ATE330970T1 (de) | 2006-07-15 |
JP2006257102A (ja) | 2006-09-28 |
EP1975173A1 (de) | 2008-10-01 |
DE69835031T2 (de) | 2007-01-18 |
ES2267199T3 (es) | 2007-03-01 |
DE69835031D1 (de) | 2006-08-03 |
AR014946A1 (es) | 2001-04-11 |
EP1041888B1 (de) | 2008-10-22 |
US6420141B1 (en) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1042363T3 (da) | Nye anti-HIV-immunogener (toxoider), fremgangsmåde til fremstilling heraf og anvendelse heraf til at forebygge og behandle AIDS | |
NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
NO911694L (no) | Mikroemulsjonsblanding til haarbehandling, fremgangsmaate for fremstilling og anvendelse derav. | |
NO991815L (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
NO975710D0 (no) | Nye Dolastatinderivater, deres fremstilling og anvendelse | |
DK0739898T3 (da) | Phosphononmoneosternukleinsyrer, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
NO973244L (no) | Fremgangsmåte for fremstilling av vannopplöselige polymerer, de oppnådde polymerer og deres anvendelse | |
DK0740668T3 (da) | Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse | |
NO922275D0 (no) | Aryletere, deres fremstilling og fremgangsmaate for behandling | |
NO973263D0 (no) | Fremgangsmåte for fremstilling og anvendelse av vandige emulsjoner | |
DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
NO984717L (no) | Nye hydroksamsyre-derivater, deres fremstilling og anvendelse | |
NO955326D0 (no) | Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
DK0795547T3 (da) | (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk | |
NO20001934D0 (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
NO941517L (no) | 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
DK0701554T3 (da) | Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse | |
NO912271D0 (no) | Somatostatinpreparater, deres fremstilling og anvendelse. | |
DK0835254T3 (da) | Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse | |
NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
DE69515285D1 (de) | Ionenimplantationsgerät und -verfahren sowie Halbleitervorrichtung | |
NO20003268L (no) | Hyperhydrert kitikolin, fremgangsmÕte og anvendelse | |
NO980929D0 (no) | Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse | |
NO955242D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse | |
NO992690D0 (no) | Nye calpainer, fremstilling og anvendelse derav |